Good evening :)
Switch to
Place Order

Gufic Biosciences Ltd

GUFICBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,861 cr, stock is ranked 737
High RiskStock is 3.07x as volatile as Nifty
196.854.85 (+2.53%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,861 cr, stock is ranked 737
High RiskStock is 3.07x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
42.08
PB RatioPB Ratio
19.42
Dividend YieldDiv. Yield
0.04%
Sector PESector PE
40.51
Sector PBSector PB
5.73
Sector Div YldSctr Div Yld
0.61%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Gufic Biosciences Limited manufactures pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Formulations, Bulk Drugs and Consumer.

Investor PresentationView older 

Nov 11, 2020

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021310.03354.94364.57491.4316.4821.9422.8644.23
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 5.01%

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnJul 12, 2021

Gufic Biosciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Gufic Biosciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Related Party Transactions 
Announced OnJul 2, 2021

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of disclosure pertaining to Related Party Transactions of the Company for the half year ended March 31, 2021. | Download

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of disclosure pertaining to Related Party Transactions of the Company for the half year ended March 31, 2021. | Download

Cash Dividend 
Ex. DateNov 3, 2020

Final • Div/Share: ₹ 0.05

See all events